These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 2548224

  • 1. Hypothalamo-pituitary-adrenal axis abnormalities in depression: a review and a model.
    Charlton BG, Ferrier IN.
    Psychol Med; 1989 May; 19(2):331-6. PubMed ID: 2548224
    [Abstract] [Full Text] [Related]

  • 2. The hypothalamic-pituitary-adrenal axis in anorexia nervosa.
    Licinio J, Wong ML, Gold PW.
    Psychiatry Res; 1996 Apr 16; 62(1):75-83. PubMed ID: 8739117
    [Abstract] [Full Text] [Related]

  • 3. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
    Twardowska K, Rybakowski J.
    Psychiatr Pol; 1996 Apr 16; 30(5):741-55. PubMed ID: 8984515
    [Abstract] [Full Text] [Related]

  • 4. The hypothalamic-pituitary-adrenal axis in depression.
    Meltzer HY, Lowy MT, Koenig JI.
    Adv Biochem Psychopharmacol; 1987 Apr 16; 43():165-82. PubMed ID: 3035885
    [No Abstract] [Full Text] [Related]

  • 5. Hypercortisolemia and depression.
    Gillespie CF, Nemeroff CB.
    Psychosom Med; 2005 Apr 16; 67 Suppl 1():S26-8. PubMed ID: 15953796
    [Abstract] [Full Text] [Related]

  • 6. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review.
    Juruena MF, Bocharova M, Agustini B, Young AH.
    J Affect Disord; 2018 Jun 16; 233():45-67. PubMed ID: 29150144
    [Abstract] [Full Text] [Related]

  • 7. The assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illness.
    Amsterdam JD, Maislin G, Gold P, Winokur A.
    Psychoneuroendocrinology; 1989 Jun 16; 14(1-2):43-62. PubMed ID: 2544002
    [Abstract] [Full Text] [Related]

  • 8. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
    Scott LV, Dinan TG.
    Life Sci; 1998 Jun 16; 62(22):1985-98. PubMed ID: 9627097
    [Abstract] [Full Text] [Related]

  • 9. Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis.
    Mello AF, Mello MF, Carpenter LL, Price LH.
    Braz J Psychiatry; 2003 Oct 16; 25(4):231-8. PubMed ID: 15328550
    [Abstract] [Full Text] [Related]

  • 10. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research.
    Stetler C, Miller GE.
    Psychosom Med; 2011 Oct 16; 73(2):114-26. PubMed ID: 21257974
    [Abstract] [Full Text] [Related]

  • 11. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression.
    Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK.
    Biol Psychiatry; 1987 Feb 16; 22(2):228-34. PubMed ID: 3028512
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical significance of the diagnostic use and assay of corticotropin-releasing hormone in the physiopathologic state of the hypothalamo-pituitary-adrenal axis].
    Nishikawa T, Yoshida A, Mikami K, Tamura Y, Yoshida S.
    Nihon Rinsho; 1990 Feb 16; 48 Suppl():182-4. PubMed ID: 2162415
    [No Abstract] [Full Text] [Related]

  • 13. Laboratory tests in depression: is it worth the effort?
    Krieg JC.
    J Psychiatr Res; 1994 Feb 16; 28(4):337-9. PubMed ID: 7877113
    [No Abstract] [Full Text] [Related]

  • 14. Emotional exhaustion and overcommitment to work are differentially associated with hypothalamus-pituitary-adrenal (HPA) axis responses to a low-dose ACTH1-24 (Synacthen) and dexamethasone-CRH test in healthy school teachers.
    Wolfram M, Bellingrath S, Feuerhahn N, Kudielka BM.
    Stress; 2013 Jan 16; 16(1):54-64. PubMed ID: 22564145
    [Abstract] [Full Text] [Related]

  • 15. New insights into the role of perinatal HPA-axis dysregulation in postpartum depression.
    Glynn LM, Davis EP, Sandman CA.
    Neuropeptides; 2013 Dec 16; 47(6):363-70. PubMed ID: 24210135
    [Abstract] [Full Text] [Related]

  • 16. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y, Spangler R, Schlussman SD, Ho A, Kreek MJ.
    Brain Res; 2003 Feb 28; 964(2):187-99. PubMed ID: 12576179
    [Abstract] [Full Text] [Related]

  • 17. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor.
    Gold PW, Chrousos G, Kellner C, Post R, Roy A, Augerinos P, Schulte H, Oldfield E, Loriaux DL.
    Am J Psychiatry; 1984 May 28; 141(5):619-27. PubMed ID: 6324597
    [Abstract] [Full Text] [Related]

  • 18. Effects of metyrapone and dexamethasone upon pro-gamma-MSH plasma levels in depressed patients and healthy controls.
    Morphy MA, Fava GA, Pedersen RC, Zielezny M, Sonino N, Brownie AC.
    J Affect Disord; 1990 Jul 28; 19(3):183-9. PubMed ID: 2170484
    [Abstract] [Full Text] [Related]

  • 19. Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer.
    Jehn CF, Kühnhardt D, Bartholomae A, Pfeiffer S, Schmid P, Possinger K, Flath BC, Lüftner D.
    Integr Cancer Ther; 2010 Sep 28; 9(3):270-5. PubMed ID: 20702499
    [Abstract] [Full Text] [Related]

  • 20. Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis.
    Rasmussen DD, Boldt BM, Bryant CA, Mitton DR, Larsen SA, Wilkinson CW.
    Alcohol Clin Exp Res; 2000 Dec 28; 24(12):1836-49. PubMed ID: 11141043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.